Quick Answer
Mirum Pharmaceuticals, Inc. reported Total Assets of $842.81 million for the year ending 2025.
- Mirum Pharmaceuticals, Inc. showed an increase of +25.7% in Total Assets from 2024 to 2025.
- This data is from Mirum Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: $104.27 million | Q3 2019: $158.27 million | Q1 2020: $172.80 million | Q2 2020: $155.77 million | Q3 2020: $141.87 million | Q1 2021: $222.24 million | Q2 2021: $247.67 million | Q3 2021: $235.17 million | Q1 2022: $278.15 million | Q2 2022: $297.23 million | Q3 2022: $364.35 million | Q1 2023: $333.53 million | Q2 2023: $443.59 million | Q3 2023: $650.64 million | Q1 2024: $651.96 million | Q2 2024: $660.75 million | Q3 2024: $667.89 million | Q1 2025: $690.25 million | Q2 2025: $725.83 million | Q3 2025: $785.12 million.
- Over the full 8 years of available data (2018 to 2025), Mirum Pharmaceuticals, Inc.'s Total Assets has grown by 1,521.6%.
- Historical annual values: Fiscal year 2025: $842.81 million | Fiscal year 2024: $670.75 million | Fiscal year 2023: $646.62 million | Fiscal year 2022: $352.91 million | Fiscal year 2021: $294.65 million | Fiscal year 2020: $240.86 million | Fiscal year 2019: $146.71 million | Fiscal year 2018: $51.98 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: